SomnoMed Limited (ASX:SOM)
Australia · Delayed Price · Currency is AUD 0.4200
0.00 (0.00%)
Aug 6, 2026, 4:10 PM AEST
SomnoMed Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, SomnoMed stock has a consensus rating of "Strong Buy" and an average price target of $0.95. The average 1-year stock price forecast is 126.19% higher than the current stock price, while the lowest is $0.75 (+78.57%) and the highest is $1.09 (+159.52%).
Price Target: $0.95 (+126.19%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for SomnoMed stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Feb '26 | Mar '26 | Apr '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgans | Morgans | Buy Maintains $0.75 | Buy | Maintains | $0.75 | +78.57% | Jul 29, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $1.00 | Buy | Maintains | $1.00 | +138.10% | Apr 16, 2026 |
Financial Forecast
Revenue This Year
119.55M
from 111.49M
Increased by 7.23%
Revenue Next Year
129.53M
from 119.55M
Increased by 8.34%
EPS This Year
0.02
from -0.01
EPS Next Year
0.03
from 0.02
Increased by 64.91%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.